DSM to form global anti-infectives joint venture with Sinochem Group - Seite 2

biotech industry. It is also a strong testimony that Sinochem is ready to
perform its social responsibility to save the energy consumption and reduce
waste discharge by leveraging biotechnology. We have full confidence in DSM´s
capability in terms of fermentation and biocatalytic conversion. The partnership
will further promote the technical breakthrough in the anti-infectives sector
and it is a strong force pushing Sinochem´s strategic development in the
biochemical industry."

Both companies are convinced that together they will be better able to capture
the growth opportunities in China and other high growth economies, combining
DSM´s proprietary technology position and global production footprint and
Sinochem´s distribution and sales capabilities and global growth ambition in
bio-pharmaceuticals. Further announcements on organization and management will
be made at closing.

Additional information
Today DSM will hold a conference call for the media from 09.00 AM - 09.30 AM CET
and a conference call for investors and analysts from 10.00 - 10.45 AM. Details
on how to access these calls can be found on the DSM website, www.dsm.com. Also,
more information can be found in the presentation that can be downloaded from
the Investors section of the DSM website.

Sinochem Group

Incorporated in 1950, Sinochem Group is one of China´s biggest central state-
owned enterprises. Sinochem has five business segments including agricultural,
energy, chemical (including pharmaceutical distribution), real estate and
finance  Sinochem has more than 200 subsidiaries and branches both in China and
abroad, among which there are four listed companies, namely Sinochem
International (SSE, 600500), SinoFert (HKEX, 00297), Franshion Properties (HKEX,
00817) and GMG. On June 1st, 2009, Sinochem made a major move to inject most of
its assets into a shareholding entity, "Sinochem Corporation". More than 40,000
employees emulate Sinochem´s spirit of exploration and innovation, adopt the
mindset of "Creating Value, Pursuing Excellence" and try their utmost to enhance
the corporate value and to build an iconic company worldwide. More information:
www.sinochem.com.

DSM Anti-Infectives

DSM Anti-Infectives is one of the world´s leading suppliers of active
pharmaceutical ingredients (APIs), and the global market leader in ß-lactam
antibiotics. Its leadership position in this biggest class of anti-infectives is
based on its use of proprietary biotechnology. These processes provide DSM Anti-
Infectives with a leadership position in terms of both cost and a significantly